 |  | About Chemagis |
| | Global Presence |
| | News & Events |
| | Environment |
| | Careers at Chemagis |
| | Contact Us |
|
|
| | | | | Montelukast Sodium | |
| Availability |
API , FDF |
| Molecular Formula |
C35H35ClNNaO3S |
| IUPAC Nomenclature |
Sodium 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetate |
| Therapeutic Category |
Asthma Prophylaxis |
| CAS Number |
151767-02-1 |
| Presentation |
4mg/5mg (as base) chewable tablets; 10mg (as base) tablets 4mg (as base) oral granules |
| Brand Name |
Singulair |
| Inventor |
MSD |
| Patents |
|
Amorphous montelukast
Novel reduction process |
US 2005/0187245
US 2006/0223999 | | |
|
| |
|
